Moderna, with aid of TBWA\Chiat\Day, is making mRNA science exciting & accessible
With the help of TBWA\Chiat\Day New York, pharma giant Moderna is demystifying mRNA science for the average consumer. This ...
centerforbiosimilars13 天
BioRationality: Should mRNA Copies Be Filed as NDAs or Biosimilars?
The article by Sarfaraz K. Niazi, PhD, argues that the FDA’s classification of future copies of messenger RNA (mRNA) products ...
ALS News Today2 天
Biopharmaceutical launches with goal to develop treatment for ALS
Trace Neuroscience has launched in the U.S. with over $100 million in financing and a goal to develop its UNC13A-targeted ...
Yahoo Finance2 天
Moderna, Inc. (MRNA)
In this article, we are going to take a look at where Moderna, Inc. (NASDAQ:MRNA) stands against other high growth large cap stocks. BlackRock highlighted that its portfolio managers are broadly ...
EurekAlert!11 天
Circular RNA-encoded protein as a novel endogenous regulator in major depressive disorder
In a paper published in Science Bulletin, a Chinese team of scientists made a significant breakthrough in major depressive ...
Fred Hutch17 天
Finding a new way to break the supply chain fueling advanced prostate cancer
Fred Hutch prostate cancer expert Dr. Andrew Hsieh won a $1M grant from the Prostate Cancer Foundation for a collaboration ...
sloveniatimes18 天
AIM Vaccine's heavyweight single-product mRNA RSV Vaccine obtained the clinical trial approval
The STA web pages use cookies to ensure proper functioning of all page features. By using our website, you agree to the use of cookies on all STA web pages.
Slow editing of protein blueprints leads to cell death
An international research team has uncovered a new mechanism crucial to the production of cellular proteins. When this ...